Sharing Progress in Cancer Care/Facebook
Nov 15, 2024, 15:48
SPCC – Overview and clarification of the current HR+ HER2- EBC treatment landscape
SPCC shared on LinkedIn:
“Mark your calendars!
In this session we will discuss:
∙ Clarification of current treatment guidelines – perspectives of clinical implementation?
∙ Benefit/cost ratio of treatment escalation and diagnostic steps vs recurrence risk
With experts Michael Gnant (AT) and Stephen Johnston (UK), and discussant FIORITA POULAKAKI (GR).
27 November – 18:00 CET
Register now.
This webinar is supported by an unrestricted educational grant from Eli Lilly.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 22, 2024, 21:35
Nov 22, 2024, 21:11
Nov 22, 2024, 21:07
Nov 22, 2024, 20:44
Nov 22, 2024, 18:19